Susan M. Flint

Susan M.
Flint worked as a Director of Technology Transfer at Pressure BioSciences, Inc. from 1995 to 1997.
She then worked as an Executive Director and Head of Clinical Operations at Oxyrane UK Ltd. and Oxyrane, Ltd. respectively.
After that, she worked as a Vice President of Clinical Operations at Navidea Biopharmaceuticals, Inc. and as a Senior Vice President of Drug Development at Alseres Pharmaceuticals, Inc. She also worked as a VP of Regulatory Affairs and Clinical Operations at EPIX Pharmaceuticals, Inc. and as a Senior Vice President of Drug Development at Cato Research LLC.
From 2014 to 2019, she worked as a Vice President and Head of Clinical Operations at Wilson Therapeutics AB. Ms. Flint received her undergraduate degree from Bridgewater State College and her graduate degree from Northeastern University.